BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 18450231)

  • 1. Kinetics of monoclonal anti-epidermal growth factor receptor antibody (IOR EGF/r3)-induced apoptosis in human carcinoma bearing nude mice.
    Ducongé J; Merino N; Alvarez D; Beausoleil I; Fernández-Sánchez E; Rodríguez L; Burt AD
    P R Health Sci J; 2008 Mar; 27(1):35-41. PubMed ID: 18450231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor.
    Modjtahedi H; Eccles S; Sandle J; Box G; Titley J; Dean C
    Cancer Res; 1994 Apr; 54(7):1695-701. PubMed ID: 8137284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice.
    Pfost B; Seidl C; Autenrieth M; Saur D; Bruchertseifer F; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R
    J Nucl Med; 2009 Oct; 50(10):1700-8. PubMed ID: 19793735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interspecies scaling of the monoclonal anti-EGF receptor ior EGF/r3 antibody disposition using allometric paradigm: is it really suitable?
    Ducongé J; Fernández-Sánchez E; Alvarez D
    Biopharm Drug Dispos; 2004 May; 25(4):177-86. PubMed ID: 15108220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new monoclonal antibody for detection of EGF-receptors in western blots and paraffin-embedded tissue sections.
    Fernandez A; Spitzer E; Perez R; Boehmer FD; Eckert K; Zschiesche W; Grosse R
    J Cell Biochem; 1992 Jun; 49(2):157-65. PubMed ID: 1400622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-EGFR activation, anti-proliferative and pro-apoptotic effects of polyclonal antibodies induced by EGFR-based cancer vaccine.
    Ramírez BS; Alpízar YA; Fernández DR; Hidalgo GG; Capote AR; Rodríguez RP; Fernández LE
    Vaccine; 2008 Sep; 26(38):4918-26. PubMed ID: 18672015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual silencing of epidermal growth factor and insulin-like growth factor 1 receptors significantly limits growth of nasopharyngeal carcinoma in nude mice.
    Zhou X; Yuan Y; Song J; Chen W; Li J; Ye L; Meng X; Xia D
    J Laryngol Otol; 2009 Feb; 123(2):208-22. PubMed ID: 18452630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of the pro-apoptotic TRAIL-receptor antibody mapatumumab with ionizing radiation strongly increases long-term tumor control under ambient and hypoxic conditions.
    Marini P; Budach W; Niyazi M; Junginger D; Stickl S; Jendrossek V; Belka C
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):198-202. PubMed ID: 19695436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immunity responses against EGFR-positive tumor cells induced by xenogeneic EGFR expressed in the yeast Pichia pastoris.
    Fang F; Chen P; Chen XC; Li J; Wen YJ; Wei YQ
    Int J Mol Med; 2009 Feb; 23(2):181-8. PubMed ID: 19148541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
    Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
    Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor.
    Crombet T; Torres O; Neninger E; Catalá M; Rodríguez N; Ramos M; Fernández E; Iznaga N; Pérez R; Lage A
    Cancer Biother Radiopharm; 2001 Feb; 16(1):93-102. PubMed ID: 11279803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK; Meeran SM; Katiyar N; Akhtar S
    Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition of human papillary thyroid carcinoma cells and multicellular spheroids by anti-EGF-receptor antibody.
    Gabler B; Aicher T; Heiss P; Senekowitsch-Schmidtke R
    Anticancer Res; 1997; 17(4B):3157-9. PubMed ID: 9329625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
    Lu M; Strohecker A; Chen F; Kwan T; Bosman J; Jordan VC; Cryns VL
    Clin Cancer Res; 2008 May; 14(10):3168-76. PubMed ID: 18483385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer of the uterine cervix is susceptible to anti-EGF-R antibody EMD 55,900 therapy.
    Solbach C; Roller M; Nicolettri M; Budischewski K; Knecht R; Kaufmann M
    Anticancer Res; 2005; 25(6B):4261-7. PubMed ID: 16309226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies targeted to TRAIL receptor-2 and ErbB-2 synergize in vivo and induce an antitumor immune response.
    Stagg J; Sharkey J; Pommey S; Young R; Takeda K; Yagita H; Johnstone RW; Smyth MJ
    Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16254-9. PubMed ID: 18838682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dual EGF/VEGF receptor tyrosine kinase inhibitor AEE788 inhibits growth of human hepatocellular carcinoma xenografts in nude mice.
    Okamoto K; Neureiter D; Alinger B; Meissnitzer M; Sass G; Schmitz V; Di Fazio P; Wissniowski T; Gahr S; Hohenstein B; Kaufmann B; Schlösser A; Haus U; Hahn EG; Herold C; Ocker M
    Int J Oncol; 2008 Oct; 33(4):733-42. PubMed ID: 18813786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice].
    Sun W; Jiang Z; Xiang TX; Tao XH; Huang AL; Wang PL
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):841-5. PubMed ID: 19595126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibition of an established A431 xenograft tumor by a full-length anti-EGFR antibody following gene delivery by AAV.
    Ho DT; Wykoff-Clary S; Gross CS; Schneider D; Jin F; Kretschmer PJ; Hermiston TW
    Cancer Gene Ther; 2009 Feb; 16(2):184-94. PubMed ID: 18758433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of human anti-VEGF165 monoclonal antibody with anti-tumor efficacy from transgenic mice expressing human immunoglobulin loci.
    Liu Y; Yun DJ; Chen JQ; Zhao JY; Liu SG; Cheng GX
    Cancer Lett; 2009 Jan; 273(1):28-34. PubMed ID: 18774636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.